Physician profile
Mary E Hall
NPI 1942318480
$948.65
in general payments reported to CMS, 2019-2025
12 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $147 · 2022: $74.40 · 2023: $280 · 2024: $257 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $203.30 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $182.92 | 2022-2025 | Farxiga |
| Boston Scientific Corporation | $170.23 | 2023-2024 | Emblem Mri S-Icd, Watchman, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $133.55 | 2021 | |
| Janssen Pharmaceuticals, INC | $63.10 | 2022-2024 | Xarelto |
| Heartflow, INC. | $47.21 | 2025 | |
| Novartis Pharmaceuticals Corporation | $34.71 | 2024 | |
| Siemens Medical Solutions USA, INC. | $27.96 | 2024 | Somatom Go.Top |
| Abiomed | $27.87 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $22.28 | 2022 | |
| Novo Nordisk INC | $22.26 | 2024 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.